For Medical Affairs Support
and Other Enquiries:

If you would like additional medical information about Vizamyl, please contact us by email at professionalservices.medical@ge.com

For other enquiries, including requests related to image reader training, please contact us by email at us.vizamyl@ge.com

Adverse events or complaints should be immediately reported to the Pharmacovigliance Safety Group at
800 654 0118 or by email at DrugSafetyPrinceton@ge.com

Should the reporter not wish to contact GE Healthcare, adverse can also be reported to the U.S Food & Drug Administration at 800 FDA 1088 or at www.fda.gov/medwatch